págs. 353-361
Monographs: Canagliflozin for the treatment of type 2 diabetes.
págs. 363-376
Monographs: Dabrafenib in the treatment of advanced melanoma.
págs. 377-385
Monographs: Insuling degludec: a long-acting modern insulin analogue with a predictable pharmacokinetic / pharmacodynamic profile.
págs. 387-397
Special report: White paper: an outlook on U.S. biosimilar competition.
págs. 399-410
© 2001-2024 Fundación Dialnet · Todos los derechos reservados